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Abstract
Saturated fatty acids are implicated in the development of insulin resistance, whereas 
unsaturated fatty acids may have a protective effect on metabolism. We tested in primary 
human myotubes if insulin resistance induced by saturated fatty acid palmitate can be 
ameliorated by concomitant exposure to unsaturated fatty acid oleate. Primary human 
myotubes were pretreated with palmitate, oleate or their combination for 12 h. Glucose 
uptake was determined by intracellular accumulation of [3H]-2-deoxy-d-glucose, insulin 
signalling and activation of endoplasmic reticulum (ER) stress by Western blotting, and 
mitochondrial reactive oxygen species (ROS) production by fluorescent dye MitoSOX. 
Exposure of primary human myotubes to palmitate impaired insulin-stimulated Akt-Ser473, 
AS160 and GSK-3β phosphorylation, induced ER stress signalling target PERK and stress 
kinase JNK 54 kDa isoform. These effects were virtually abolished by concomitant exposure 
of palmitate-treated myotubes to oleate. However, an exposure to palmitate, oleate or 
their combination reduced insulin-stimulated glucose uptake. This was associated with 
increased mitochondrial ROS production in palmitate-treated myotubes co-incubated with 
oleate, and was alleviated by antioxidants MitoTempo and Tempol. Thus, metabolic and 
intracellular signalling events diverge in myotubes treated with palmitate and oleate. 
Exposure of human myotubes to excess fatty acids increases ROS production and induces 
insulin resistance.
Introduction
Excess dietary fat and sedentary lifestyle predispose to 
insulin resistance and type 2 diabetes. As skeletal muscle 
accounts for 80% of glucose disposal under insulin-
stimulated conditions (1, 2), it is an important target 
tissue to study insulin action. Increased fat availability 
and reduced fatty acid oxidation in skeletal muscle from 
obese type 2 diabetic people favour ectopic storage of fat 
in muscle (3). This has been suggested to induce insulin 
resistance via generation of active fatty acid-derived 
metabolites, such as diacylglycerol (DAG), long-chain 
fatty acyl-CoA:s and ceramides. These metabolites 
can interfere with insulin signal transduction (4). 
Mitochondrial fat overload and incomplete oxidation of 
fatty acids have also emerged as players in pathogenesis 
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Table 1 Clinical characteristics of the healthy male 
volunteers studied.
N 8
Age (years) 55 ± 3
BMI (kg/m2) 23.2 ± 0.7
Waist (cm) 90 ± 4
Hip (cm) 96 ± 1
Waist-to-hip ratio 0.94 ± 0.03
Systolic blood pressure (mmHg) 141 ± 6
Diastolic blood pressure (mmHg) 87 ± 4
Fasting plasma glucose (mmol/L) 5.5 ± 0.2
HbA1c (% (mmol/mol)) 5.4 ± 0.1 (36 ± 1)
Fasting cholesterol (mmol/L) 5.4 ± 0.4
Fasting HDL cholesterol (mmol/L) 1.5 ± 0.2
Fasting LDL cholesterol (mmol/L) 3.3 ± 0.5
Fasting triacylglycerols (mmol/L) 1.4 ± 0.2
Data are presented as mean ± s.e.m.


















of muscle insulin resistance (5). However, the molecular 
mechanisms whereby excess fatty acids lead to reduced 
insulin action are still incompletely understood.
Increased intake of saturated fatty acids leads to insulin 
resistance (6, 7). Conversely, diet high in monounsaturated 
fatty acids has been associated with improved 
insulin sensitivity (7, 8). Mediterranean diet is rich in 
monounsaturated fatty acids and low in saturated fats, and 
it has been shown to protect against major cardiovascular 
events (9) and T2D (10). However, the beneficial effect of 
monounsaturated fat on insulin sensitivity has been lost 
if the overall fat intake has been high (7). Taken together, 
these data indicate that both quality and quantity of 
dietary fat play a role in regulating insulin sensitivity.
Recent cell-based studies have provided evidence that 
co-incubation with monounsaturated fatty acid oleate 
protects against saturated fatty acid palmitate-induced 
insulin resistance (11, 12, 13). Since data on human 
skeletal muscle are limited, the current study was initiated 
to explore whether there is a similar interaction with 
different fatty acids in primary human muscle cells. We 
tested if adding oleate to palmitate would protect muscle 
cells from palmitate-induced insulin resistance.
Materials and methods
Participants
The study was reviewed and approved by the Ethical 
Committee of Department of Medicine, Helsinki 
University Central Hospital, and written informed consent 
was obtained from all subjects before participation. The 
reported investigations have been carried out in accordance 
with the principles of the Declaration of Helsinki as revised 
in 2008. We studied 8 healthy nonsmoking men (Table 1). 
None of the subjects was taking any medications, and all 
had normal glucose tolerance in standard (75 g glucose) oral 
glucose tolerance test (WHO criteria). Subjects were studied 
after an overnight fast and were instructed to abstain from 
physical exercise for at least 72 h before the studies.
Muscle cell preparation
Satellite cells were isolated, and primary human muscle 
cell cultures were established as described (14). In brief, 
after obtaining a biopsy from vastus lateralis muscle under 
local anaesthesia (10 mg/mL lidocain hydrochloride), the 
muscle tissue was dissected into small pieces, followed by 
trypsinization in a shaking water bath at +37°C for 1 h. 
Satellite cells were isolated and maintained in DMEM-F12 
culture medium (Gibco/Thermo Fisher Scientific) contain-
ing 20% fetal bovine serum (FBS), 1% penicillin, 1% 
streptomycin and 1% fungizone. Primary myoblasts were 
separated from non-myogenic cells with CD56-coupled 
magnetic beads (Miltenyi Biotec, Gologne, Germany). 
To obtain myotubes, myoblasts at 80% confluence were 
switched to differentiation medium containing 2% FBS 
for 5–7 days. The cells were serum starved for 2 h before 
any treatment in low-glucose DMEM supplemented 
with 0.5% fatty acid-free BSA and 4 mM l-glutamine. All 
chemical treatments were prepared in starvation medium 
supplemented with 2 mM l-carnitine (5).
Pre-treatment with BSA-conjugated fatty acids
Fatty acids conjugated with BSA and vehicle control–
BSA-NaOH were prepared before each experiment based 
on previously reported procedure (15). Primary human 
myotubes were pretreated with 0.4 mM palmitate or 
0.2 mM oleate, or with combination of 0.4 mM palmitate 
and 0.2 mM oleate, at 37°C for 12 h. In some experiments, 
myotubes were pretreated with antioxidants MitoTempo 
(50 µM) or Tempol (0.5 mM) for 12 h with or without the 
combination of palmitate (0.4 mM) and oleate (0.2 mM).
Glucose uptake
Glucose uptake was measured in triplicate, as described 
(14, 16). In brief, myotubes pretreated with or without 
fatty acids were stimulated with or without 100 nM 
insulin (Actrapid, Novo Nordisk) for 1 h at +37°C in 
the pre-treatment medium, washed from glucose and 
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Phosphorylation of Akt-Ser473, AS160 and GSK-3β. Human primary 
myotubes were incubated with 0.4 mM palmitate (PA), 0.2 mM oleate 
(OA) or their combination (PA + OA), for 12 h, and stimulated with 100 nM 
insulin for 10 min. Phosphorylation of Akt-Ser473 (A), AS160 (B) and 
GSK-3β (C) was assessed. Data are expressed as mean ± s.e.m. from 5 men. 
*P < 0.05 compared to insulin-stimulated control, two-way ANOVA with 
repeated measurements, Sidak’s post hoc test (A and B), Student’s paired 
t-test (C). AU, arbitrary units.


















other compounds followed by 15 min incubation in 
glucose-free DMEM medium containing 0.5% fatty acid-
free BSA, 10 µM 2-DG and [3H]-2-deoxy-d-glucose (100 mCi/
mmol). Myotubes were washed with ice-cold PBS and lysed 
in 0.4 M NaOH for 3 h on a rotating platform. Radioactivity 
of the cell lysate was measured in a scintillation counter.
Western blot analysis
Myotubes pretreated with or without fatty acids were 
stimulated with or without 100 nM insulin for 10 min 
at +37°C. Total and phosphorylated proteins were 
detected by Western blotting in PVDF membranes with 
primary antibodies from Cell Signaling: p-AktSer473 
(#9271), total Akt (#9272), pAS160Thr642 (#4288), total 
AS160 (#2447), p-GSK-3βSer9 (#9336), total GSK-3β 
(#9315), total PERK (#3192), p-JNKThr183/Tyr185 (#9251), 
total JNK (#9252), total AMPK (#2532), from Santa 
Cruz: p-PERKThr981 (#sc-32577) and from Millipore: 
p-AMPK (#07-626). Primary antibodies were detected 
with horseradish peroxidase-conjugated secondary 
antibody, visualized by enchanced chemiluminescence 
(Pierce ECL 2 Western Blotting Substrate, Thermo 
Scientific) and quantified using ImageJ software (NIH, 
http://rsbweb.nih.gov/ij/).
Measurement of mitochondrial ROS production
Mitochondrial ROS levels were measured using fluorescent 
dye MitoSOX (Molecular Probes, Invitrogen). Cells were 
incubated with dye at +37°C in pre-treatment medium. 
After 45 min, cells were washed from the dye, trypsinized 
and resuspended in normal Tyrode’s solution (140 mM 
NaCl, 5 mM KCl, 1.5 mM CaCl2, 1 mM MgCl2, 10 mM 
HEPES, 5 mM d-glucose, pH 7.4) for measurement of 
fluorescent intensity in a BD Accuri C6 (BD Biosciences, 
San Jose, CA, USA). The dye was excited at 488 nm, and 
fluorescent emission was collected through FL3 channel.
Reagents
Trypsin, FBS, penicillin/streptomycin, low-glucose 
DMEM, l-glutamine, palmitic acid, oleic acid, Tempol, 
2-DG, l-carnitine and sodium pyruvate were from 
Sigma. DMEM-F12, glucose-free DMEM, MitoTempo and 
fungizone were from Gibco. [3H]-2-deoxy-d-glucose was 
from PerkinElmer. CD56-coupled magnetic beads were 
from Miltenyi Biotec (Gologna, Germany), and Actrapid 
insulin was from Novo Nordisk.
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Phosphorylation of PERK, JNK54 and AMPK. Human primary myotubes 
were incubated with 0.4 mM palmitate (PA), 0.2 mM oleate (OA) or their 
combination (PA + OA), for 12 h, and stimulated with 100 nM insulin for 
10 min. Phosphorylation of PERK (A), JNK54 (B) and AMPK (C) was 
assessed. Data are expressed as mean ± s.e.m. from 4 (A, B) and 5  
(C) men. **P < 0.01 and ***P < 0.001 compared to respective control, 
two-way ANOVA with repeated measurements, Sidak’s post hoc test. 
AU, arbitrary units.



















Data are presented as mean ± s.e.m. Statistical analyses 
were performed using GraphPad Prism statistical 
software (version 6). One- or two-way ANOVA with 
repeated measurements followed by Sidak’s post hoc 
test for multiple comparisons or paired Student’s t-test 




Akt-Ser473 Primary human myotubes were incubated 
with palmitate, oleate or their combination for 12 h. 
Palmitate caused a profound reduction in insulin action 
on Akt-Ser473 signalling, whereas oleate did not have 
an effect. Co-incubation with palmitate and oleate 
completely restored and even enhanced insulin action on 
Akt-Ser473 phosphorylation (Fig. 1A).
AS160 Incubation with palmitate inhibited insulin-
stimulated AS160 phosphorylation, and this was rescued 
by co-incubation with oleate (Fig. 1B).
GSK-3β Palmitate led to a decrease in insulin-stimulated 
GSK3β phosphorylation, which was recovered by co-
incubation with oleate (Fig. 1C).
ER stress and AMPK signalling
PERK Incubation with palmitate for 12 h induced ER 
stress as observed by increased PERK phosphorylation. 
This was restored by co-incubation with oleate (Fig. 2A).
JNK Activation of stress kinase JNK signalling is 
implicated in response to ER stress (17). Palmitate 
increased the phosphorylation of JNK isoform of 54 kDa 
in muscle cells. Co-incubation with palmitate and oleate 
prevented JNK activation (Fig. 2B).
AMPK Phosphorylation of AMP-activated protein kinase 
was increased in myotubes pretreated with palmitate and 
oleate for 12 h (Fig. 2C).
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Glucose uptake. Human primary myotubes were pre-exposed to 0.4 mM 
palmitate (PA), 0.2 mM oleate (OA) or their combination for 12 h before 
analysis of glucose uptake with or without 100 nM insulin. Data  
(in pmol/mg protein/min) were normalized to insulin-stimulated glucose 
uptake (control) of each subject. Data are expressed as mean ± s.e.m. from 
5 men **P < 0.01 vs respective control, two-way ANOVA with repeated 
measurements, Sidak’s post hoc test. AU, arbitrary units.
Figure 4
(A) Mitochondrial ROS. Human primary myotubes were pre-exposed to 
0.4 mM palmitate (PA), 0.2 mM oleate (OA), or their combination for 12 h. 
Mitochondrial ROS production was determined as described in the 
‘Materials and methods’ section. Data are expressed as mean ± s.e.m. from 5 
men. *P < 0.05 compared to basal, one-way ANOVA with repeated 
measurements, Sidak’s post hoc test. (B) Glucose uptake with MitoTempo. 
Human primary myotubes were pre-exposed for 12 h to a combination of 
0.4 mM palmitate (PA) and 0.2 mM oleate (OA), with or without 50 µM 
MitoTempo (MT), before analysis of glucose uptake with or without 100 nM 
insulin. Data are expressed as mean ± s.e.m. from 6 men *P < 0.05 and 
***P < 0.001 vs respective control, two-way ANOVA with repeated 
measurements, Sidak’s post hoc test. (C) Glucose uptake with Tempol. 
Human primary myotubes were pre-exposed for 12 h to a combination of 
0.4 mM palmitate (PA) and 0.2 mM oleate (OA), with or without 0.5 mM 
Tempol (Tem), before analysis of glucose uptake with or without 100 nM 
insulin. Data are expressed as mean ± s.e.m. from 6 men **P < 0.01 and 
***P < 0.001 vs respective control, two-way ANOVA with repeated 
measurements, Sidak’s post hoc test.
Glucose metabolism
Glucose uptake To analyse if the observed changes 
in signalling events are reflected at glucose metabolism, 
human primary myotubes were pre-exposed to palmitate, 
oleate or their combination for 12 h before analysis of 
insulin-stimulated glucose uptake. Exposure to either 
palmitate or oleate or their combination reduced basal or 
insulin-stimulated glucose uptake (Fig. 3).
Mitochondrial ROS production
Since metabolism of fatty acids leads to ROS production 
(18), we next analysed if development of insulin resistance 
of glucose uptake is related to ROS. Human myotubes were 
exposed for 12 h to palmitate, oleate or their combination. 
Mitochondrial ROS production was significantly increased 
in cells incubated with both palmitate and oleate, but not 
with palmitate or oleate alone (Fig. 4A).
Antioxidants We next tested if insulin responsiveness 
in myotubes exposed to fatty acids can be restored by 
using antioxidants. Concomitant exposure of myotubes to 
mitochondrial-targeted antioxidant MitoTempo restored 
and even enhanced basal and insulin-stimulated glucose 
uptake in myotubes treated with both palmitate and 
oleate (Fig. 4B). Exposure to MitoTempo alone increased 
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basal and insulin-stimulated glucose uptake. Tempol, a 
small molecule cell-permeable SOD mimetic, also restored 
basal and insulin-stimulated glucose uptake in myotubes 
treated with fatty acids, and enhanced basal and insulin-
stimulated glucose uptake in untreated cells (Fig. 4C).
Discussion
Here, we show that exposure of primary human myotubes 
from healthy donors to saturated fatty acid palmitate 
impairs insulin signalling, increases ER stress and 
activates stress kinase JNK signalling. Co-incubation of 
primary human myotubes with monounsaturated fatty 
acid oleate has a protective effect by restoring defects at 
insulin signalling, and preventing activation of ER stress 
and JNK. However, the changes at the level of signalling 
are not translated into metabolic events, since provision 
of myotubes with both palmitate and oleate results in 
impairment of insulin action on glucose uptake. This is 
related to increased mitochondrial ROS production, and 
can be ameliorated with antioxidants.
The strength of our study is that we used carefully 
controlled conditions to study effects of saturated fatty 
acid palmitate and unsaturated fatty acid oleate in 
myotubes from clinically well-characterized healthy 
donors. The weaknesses of our study are that we only 
studied men and the sample size was limited. Moreover, 
we used only one concentration of palmitate (0.4 mM) and 
oleate (0.2 mM). However, we performed an initial dose-
response and time-course experiment using palmitate 
at different concentrations (0.1, 0.2 and 0.4 mM) for a 
duration of 4, 8 or 12 h, and we observed a time- and dose-
dependent inhibition of insulin-stimulated Akt-Ser473 
phosphorylation, with the maximum inhibition at 12 h 
by 0.4 mM palmitate (data not shown here). Therefore, 
we chose to expose the cells to 0.4 mM palmitate for 12 h 
in the subsequent experiments. Oleate concentration 
was chosen based on the study by Peng and coworkers 
where the negative effects of 0.5 mM palmitate could be 
combated by concomitant exposure to lower (0.1–0.2 mM 
or 0.3 mM) oleate concentrations (12). In the future, it 
would be important to compare the effects of different 
fatty acid concentrations, and the effects of different fatty 
acids with varying chain lengths and degrees of saturation, 
on metabolism in human skeletal muscle. It would also be 
interesting to compare the effects of exposing muscles to 
different proportions of unsaturated to saturated fats.
However, our observations on the effects of different 
fatty acids were robust. Interestingly, several in vivo studies 
have provided compelling evidence that substituting 
saturated fat for mono- and polyunsaturated fatty acids 
improves metabolic health and protects against coronary 
artery disease (7, 8, 9, 10, 19). In contrast, diet enriched 
in saturated fatty acids, a typical Western diet, aggravates 
insulin resistance (6, 7, 20). These data suggest that 
different fatty acids are indeed not alike, which was also 
apparent in our study where the effects of palmitate and 
oleate on intracellular signalling in human myotubes 
diverged. It is possible that differential routing of fatty acids 
contributes to variable impact of fatty acids. Clinically, 
this is evident, for example, in an overfeeding experiment, 
where overconsumption of saturated fatty acids leads 
to more increased hepatic and visceral fat storage than 
overconsumption of polyunsaturated fatty acids, despite 
similar weight gain (21). Moreover, an isocaloric diet 
rich in polyunsaturated fatty acids diminishes hepatic fat 
content and may improve insulin resistance in viscerally 
obese people (22).
Our data on human myotubes are also in agreement 
with other in vitro studies. The beneficial effect of adding 
monounsaturated oleate to cells exposed to saturated 
fatty acid palmitate has been convincingly demonstrated 
(11, 12, 13, 23, 24, 25, 26). Several mechanisms seem to 
be operative. In agreement to our observations, palmitate 
reduces insulin-stimulated phosphorylation of Akt. This is 
rescued by concomitant exposure to oleate (12, 25), an effect 
suggested to involve inhibition of protein phosphatase 
2A (13). Palmitate activates diacylglycerol/PKC-θ/NF-κB 
pathway in mouse C2C12 myotubes, which results in 
increased interleukin-6 secretion and downregulation 
of PGC-1α and DGAT2. Co-incubation with oleate 
prevents these negative sequelae, which is suggested to be 
mediated by enhanced mitochondrial β-oxidation and by 
channelling palmitate into triglycerides (11). In another 
experiment, palmitate inhibited insulin signalling and 
increased mitochondrial ROS production. Addition of 
oleate to palmitate restored insulin signalling, increased 
ATP levels and cell viability (25). Similarly, palmitoleate, a 
monounsaturated fatty acid, protected from the negative 
effects of palmitate on glucose uptake (27).
ER stress has been suggested to play a role in the 
pathogenesis of insulin resistance (28). Here, we observed 
an activation of ER stress signalling, as reflected by 
increased PERK. This was associated with the activation 
of stress kinase JNK. Protein kinase JNK is activated via 
IRE1 of the unfolded protein response (UPR) signalling 
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pathway (17), and it phosphorylates IRS at inhibitory 
serine residues and thus contributes to insulin resistance 
by blocking PI3K pathway (29, 30). We demonstrate that 
co-incubation with oleate protects human myotubes from 
palmitate-induced activation of ER stress and JNK. This is 
in agreement with a study by Peng and coworkers where 
co-incubation of L6 and C2C12 muscle cells with palmitate 
and oleate protected cells from ER stress (12). These 
observations have also been confirmed by others. Studies 
using mouse C2C12 myotubes and human myogenic 
cell line LHCN-M2 have revealed that co-incubation 
with oleate prevents palmitate-induced increase in ER 
stress markers (31). One possible mechanism relates 
to partitioning of intracellular lipids, as oleate directs 
palmitate into triglyceride pool. This reduces cellular 
active lipid metabolites such as phospholipids, DAG or 
ceramide (11, 12, 23). Palmitate-induced activation of ER 
stress markers is also prevented by AICAR and A-769662, 
compounds both of which activate AMPK. Expression of 
dominant-negative AMPK or AMPK inhibitor compound 
C prevents the beneficial effects of oleate on palmitate-
induced ER stress, inflammation and insulin resistance 
(31). These data suggest that the protective effects of oleate 
may be mediated via AMPK activation. In agreement, we 
observed increased AMPK phosphorylation in myotubes 
co-incubated with palmitate and oleate, although this was 
not within the scope of our study.
ROS are formed in mitochondria during aerobic 
metabolism. Oxidative stress is present in many 
physiological as well as pathophysiological states such 
as exercise and insulin resistance (32, 33). Chronic 
hyperinsulinemia and exposure to cytokine TNFα, 
dexamethasone or palmitate induce insulin resistance 
in 3T3-L1 adipocytes and in L6 myotubes. Each of these 
insults increases mitochondrial superoxide production, 
and insulin resistance can be reversed using interventions 
such as mitochondrial antioxidants or MnSOD expression. 
Thus, mitochondrial superoxide production is a common 
denominator in multiple insults that contribute to insulin 
resistance (33). Exposure of skeletal muscle mitochondria 
to even low concentrations of fatty acids results in 
enhanced ROS production (18). High-fat diet increases 
H2O2 emitting potential of muscle mitochondria and leads 
to changes in redox balance and redox buffering capacity. 
Moreover, insulin resistance following a diet with high-
fat content can be overcome by mitochondrial-targeted 
antioxidant or overexpression of mitochondrial-targeted 
catalase which catalyzes conversion of H2O2 to H2O (34). 
Overall, our data are in agreement with these observations. 
When we exposed primary human myotubes to fatty 
acids, insulin action on glucose uptake was reduced, and 
an exposure to a combination of palmitate and oleate 
increased mitochondrial ROS production. When we 
treated the fatty acid-exposed cells with antioxidants, 
there was an amelioration of insulin resistance. These data 
support the concept that energy excess leads to enhanced 
mitochondrial ROS production and insulin resistance.
In conclusion, while monounsaturated fatty acid 
oleate protected human muscle cells from palmitate-
induced alterations in intracellular signalling, this did not 
result in protection against insulin resistance – insulin 
action on glucose uptake remained impaired. Overall, our 
data fit with the emerging concept that in a situation when 
energy is provided in excess of energy need, cells respond 
with development of insulin resistance (35). Therefore, 
calorie restriction and energy expenditure-increasing 
interventions, such as exercise, remain the cornerstones 
of treatment of people with insulin resistance.
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